(Q34698761)

English

Olmesartan medoxomil

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

Olmesartan medoxomil (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Gregory T Warner

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Blair Jarvis

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1345-53; discussion 1354-6

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Anti-atherosclerotic efficacy of olmesartan

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New pharmacologic aspects of CS-866, the newest angiotensin II receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time to patient discontinuation of antihypertensive drugs in different classes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensives.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily regimen and compliance with treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies of CS-866, the newest angiotensin II receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12076183

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200262090-00005

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34698761&oldid=2196957964"